REDCARE PHARMACY NV (RDC.DE) Stock Analyst Earnings Estimates
FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.06B 9.52% | 1.204B 13.59% | 1.799B 49.35% | 2.401B 33.48% | 2.989B 24.49% | 3.597B 20.34% | 4.242B 17.93% | 4.685B 10.44% | 5.075B 8.32% | 5.69B 12.12% | 6.138B 7.87% | 6.477B 5.52% | |
| EBITDA YoY % growth | -38.94M -358.57% | -13.99M 64.07% | 49.669M 455.03% | 44.911M -9.58% | 91.851M 104.52% | 152.74M 66.29% | 265.82M 74.03% | 363.59M 36.78% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -65.9M -6,490.00% | -53.5M 18.82% | -7.619M 85.76% | -30.09M -294.93% | -4.33M 85.61% | 69.344M 1,701.32% | 141.37M 103.87% | 209.46M 48.16% | 229.94M 9.78% | 265.93M 15.65% | N/A | N/A | |
| Operating Margin | -6.22% | -4.44% | -0.42% | -1.25% | -0.14% | 1.93% | 3.33% | 4.47% | 4.53% | 4.67% | N/A | N/A | |
| EPS YoY % growth | N/A -338.15% | N/A -46.28% | N/A 74.56% | -1.93 -91.90% | -0.90 53.24% | 1.70 288.79% | 7.35 332.12% | 9.50 29.30% | N/A | N/A | N/A | N/A |
All data in EUR
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.93 |
| Revenue Q2Q % growth | 690.64M 29.99% |
| EBITDA Q2Q % growth | 7.02M -86.81% |
| EBIT Q2Q % growth | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.35 | -0.66 | 0.31 | 47.25% |
| Q2 2024 Q2Q % growth | -0.21 | -0.08 | -0.13 | -159.90% |
| Q4 2021 Q2Q % growth | -2.46 | -1.29 | -1.17 | -90.28% |
| Q3 2021 Q2Q % growth | -0.79 | -0.49 | -0.30 | -59.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 574.548M 20.83% | 581.98M | -7.432M | -1.28% |
| Q2 2024 Q2Q % growth | 560.674M 33.53% | 380.37M | 180.304M | 47.40% |
| Q1 2024 Q2Q % growth | 560.216M 50.56% | % | ||
| Q4 2023 Q2Q % growth | 531.318M 62.09% | % | ||
| Q3 2023 Q2Q % growth | 475.5M 67.14% | % | ||
| Q2 2023 Q2Q % growth | 419.9M 46.20% | % | ||
| Q1 2023 Q2Q % growth | 372.1M 22.08% | % | ||
| Q4 2022 Q2Q % growth | 327.8M 13.82% | % | ||
| Q3 2022 Q2Q % growth | 284.5M 19.59% | % | ||
| Q2 2022 Q2Q % growth | 287.2M 14.70% | % | ||
| Q1 2022 Q2Q % growth | 304.8M 7.29% | % | ||
| Q4 2021 Q2Q % growth | 288M 8.80% | 293.18M | -5.18M | -1.77% |
| Q3 2021 Q2Q % growth | 237.9M -0.34% | 248.93M | -11.03M | -4.43% |
| Q2 2021 Q2Q % growth | 250.4M 7.61% | % | ||
| Q1 2021 Q2Q % growth | 284.1M 22.46% | % | ||
| Q4 2020 Q2Q % growth | 264.7M 37.94% | % | ||
| Q3 2020 Q2Q % growth | 238.7M 39.67% | % | ||
| Q2 2020 Q2Q % growth | 232.7M 42.24% | % | ||
| Q1 2020 Q2Q % growth | 232M 32.88% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -389.84% | -56.3% | -56.3% |
| Revenue | 0% | N/A | -0.04% | -0.08% |